URISPAS SKF (Urispas 100 mg)

Generic Name: flavoxate

Pill imprint URISPAS SKF has been identified as Urispas 100 mg.

Urispas is used in the treatment of dysuria; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Urispas 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Urispas

Generic Name:

flavoxate

Imprint:

URISPAS SKF

Strength:

100 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Urinary antispasmodics

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

GlaxoSmithKline

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.